Previous work has demonstrated that fusion of a luciferase to an opsin, to create a luminescent opsin or luminopsin, provides a genetically encoded means of manipulating neuronal activity via both chemogenetic and optogenetic approaches. Here we have expanded and refined the versatility of luminopsin tools by fusing an alternative luciferase variant with high light emission, Gaussia luciferase mutant GLucM23, to depolarizing and hyperpolarizing channelrhodopsins with increased light sensitivity. The combination of GLucM23 with Volvox channelrhodopsin-1 produced LMO4, while combining GLucM23 with the anion channelrhodopsin iChloC yielded iLMO4. We found efficient activation of these channelrhodopsins in the presence of the luciferase substrate, as indicated by responses measured in both single neurons and in neuronal populations of mice and rats, as well as by changes in male rat behavior during amphetamine-induced rotations. We conclude that these new luminopsins will be useful for bimodal opto-and chemogenetic analyses of brain function.
. In these LMOs, bioluminescence produced by oxidation of a diffusible luciferin substrate by the luciferase enzyme activates a tethered, nearby opsin.
Depending on the biophysical properties of the opsin, the light generated by the luciferase can either excite or inhibit target neurons expressing the LMO. Such integration of opto-and chemogenetic approaches allows manipulation of neural activity over a range of spatial and temporal scales in the same experimental animal. Specifically, LMOs allow rapid optogenetic control of the activity of subsets of neurons as well as slower chemogenetic control of the activity of entire populations of neurons.
Initially, wild-type Gaussia luciferase (GLuc) (Verhaegen & Christopoulos, 2002) was combined with channelrhodopsin 2 (ChR2) (Nagel et al., 2003) to yield the excitatory LMO1 (Berglund et al., 2013) , while combination of the red-shifted Renilla luciferase version TagRFP-RLuc (Dragulescu-Andrasi, Chan, De, Massoud, & Gambhir, 2011) with Natronomonas halorhodopsin (NpHR) (Gradinaru, Thompson, & Deisseroth, 2008) resulted in the inhibitory iLMO1 (Tung et al. 2015) . The performance of subsequent LMO versions was significantly improved by using luciferase variants with higher light emission, such as the GLuc variants "slow burn" (sbGLuc) (Welsh, Patel, Manthiram, & Swartz, 2009 ) and "superluminescent" (slGLuc) (Kim, Suzuki, Sato, & Tao, 2011) , as well as the RLuc-based luciferase-fluorescent fusion protein Nano-lantern (Saito et al., 2012) . These probes allowed activation and silencing of neurons via noninvasive peripheral application of the luciferase substrate in freely moving mice and rats, resulting in observable changes in their behavior (Berglund et al., 2016; Tung et al., 2015) .
While the current LMOs are usable, their performance is not fully optimized. Here we have explored the potential of a new GLuc mutant with very efficient light generation, GLucM23 (Lindberg, Mizukami, Ibata, Miyawaki, & Kikuchi, 2013) , as the light-emitting moiety in LMOs. By fusing GLucM23 to the depolarizing opsin Volvox channelrhodopsin-1 (VChR1), we created a fourth-generation excitatory LMO, LMO4. Similarly, by fusing GLucM23 to a hyperpolarizing anion channelrhodopsin, iChloC (Wietek et al., 2015) , we created a novel inhibitory LMO, iLMO4. Validation of these new constructs, both in vitro and in vivo, revealed that these new LMOs have the highest known coupling between the luciferase enzyme and the opsin actuators. We conclude that these new LMOs are useful additions to the LMO tool set for bimodal opto-and chemogenetic experiments.
| MATERIALS A ND METHODS

| Constructs
The generation of LMO plasmids is described in detail in Berglund et al. (2013) . For the new versions of LMOs, the wild-type GLuc sequence in LMO2 (GLuc-VCHR1-EYFP) was replaced by the mutated version GLucM23 to generate LMO4 (GLucM23-VChR1-EYFP). Switching out VChR1 with the synthesized sequence for iChloC (Genscript, Piscataway, NJ) generated iLMO4 (GLucM23-iChloC-EYFP). For viral vectors, the coding sequences of LMO4 and iLMO4 were cloned into an AAV vector downstream of a human synapsin promoter as described previously (Berglund et al., 2016) .
| Cell culture
Human embryonic kidney fibroblasts (HEK293, RRID:CVCL_0045; and HEK293FT, RRID:CVCL_6911) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS), 100 U penicillin, and 0.1 mg streptomycin per milliliter, at 37 8C and 5% CO 2 in a humidified atmosphere. Cells were transfected using Lipofectamine 2000 (Invitrogen, Waltham, MA) according to the manufacturer's protocol. For luminescence experiments 1 3 10 4 cells were seeded in white 96-well plates (BD Falcon, Franklin Lakes, NJ). Cells were used for luminescence experiments 36 hr after transfection.
For in vitro electrophysiology studies, primary hippocampal neurons were cultured from newborn mouse pups (P0-P2) of both sexes of strain B6129F1 hybrid (RRID:IMSR_TAC:b6129) as described previously (Berglund et al., 2013) . Lipofection was used for transfecting cultured neurons on days in vitro (DIV) 2 to 4. We used 1/10th of the recommended amount of Lipofectamine and otherwise followed the manufacturer's protocol. Cells were plated in culture medium consisting of Neurobasal Medium (Invitrogen) containing B-27 (Invitrogen), 2 mM Glutamax (Invitrogen), and 5% FCS (NB-FCS). The medium was replaced with culture medium without serum the next day (NB-Plain).
For multielectrode array (MEA) experiments, primary neurons were collected from embryonic day 18 rat embryos of both sexes from Sprague-Dawley females (RRID:RGD_5508397) obtained directly from a commercial vendor (Harlan) or from BrainBits, LLC. Neurons were transduced with virus on DIV2. Virus was added to the culture medium (1 ml per well of concentrated stocks). All supplements were purchased from Gibco/Invitrogen/Thermo Fisher unless indicated otherwise.
| Virus
AAVs carrying LMOs were produced by transfecting subconfluent HEK293FT cells per 10-cm culture dish with 24 lg of the helper plasmid pAd delta F6, 20 lg of the serotype plasmid AAV2/9, and 12 lg of the LMO3 plasmid using Lipofectamine 2000. After 72 hr, supernatant was harvested from culture plates and virus was purified from cells and supernatant following the method of Guo et al. (2012) , but without the partitioning step in the aqueous 2-phase system (Berglund et al., 2016) . Viral titers were determined by q-PCR for the WPRE element. Preparations with titers ranging from 1 3 10 10 to 1 3 10 13 vg/ml were used in this study.
| Coelenterazine
The luciferin, coelenterazine (CTZ), was purchased from Nanolight Technology (Pinetop, AZ). For in vitro experiments, CTZ free base, the natural form of CTZ (Nanolight cat. no. 303), was dissolved in NanoFuel (Nanolight cat. no. 399) or acidified ethanol (0.06 N HCl).
Reconstituted CTZ was prediluted 1:500 in NB-Plain and added to neuron cultures for a final concentration of 100 mM for recordings. For in vivo experiments, water-soluble CTZ (Nanolight cat. no. 3031) was used, and water-soluble buffer only, without CTZ (Nanolight cat. no. 3031C), was used as a vehicle control.
| Bioluminescence imaging of cells
To measure luminescence from HEK cells, reconstituted and diluted CTZ was added to the culture medium immediately before imaging to the final concentration indicated in the experiment. Luminescence was measured using an IVIS Lumina LT In Vivo Imaging System (PerkinElmer, Waltham, MA) with Living Image 4.5.2 software (RRID: SCR_014247). Images were displayed as a pseudo-color photon counted image. Regions of interest were defined using an automatic intensity contour procedure to identify bioluminescent signals with intensities significantly greater than background. The sum of the photon counts in these regions was then calculated.
| Electrophysiology and bioluminescence imaging in neurons
Whole-cell patch clamp recordings were made from cultured hippocampal neurons, as described in Berglund et al. (2013 Berglund et al. ( , 2016 , using an EPC-9D amplifier (HEKA Elektronik, Lambrecht, Germany). For voltage clamp measurements of photocurrents, neurons were held at a holding potential of 260 mV. When measuring light-induced potential changes, neurons were held at the zero current level in current clamp mode.
Recording pipettes had resistances of 4 to 5 MX and were filled with an internal solution containing 140 mM K-gluconate, 2 mM MgCl 2 , 0.5 mM CaCl 2 , 10 mM HEPES, 4 mM Na2-ATP, 0.4 mM Na3-GTP, and 5 mM EGTA (pH 7.1 titrated with KOH). The extracellular solution consisted of 150 mM NaCl, 3 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 20 mM D-glucose, and 10 mM HEPES (pH 7.35, titrated with NaOH).
Photocurrents were measured while illuminating neurons with a mercury lamp via a GFP filter cube (excitation, 465-495 nm); these currents provided a measure of the total surface expression of LMO4 or iLMO4 in each cell. Reconstituted CTZ (100 lM) in extracellular solution was bath applied to a recording chamber for recording CTZinduced responses, either photocurrents under voltage clamp or potential changes under current clamp.
Bioluminescence was imaged simultaneously on the same microscope (Olympus IX70), without a filter cube, by using a cooled CCD camera, CoolSNAP fx (Photometrics, Tucson, AZ), with 4-by-4 binning and 5-s exposure. Metamorph (Molecular Devices, Sunnyvale, CA; RRID:SCR_002368) and ImageJ software (NIH, Bethesda, MD; RRID: SCR_003070) were used for image acquisition and analysis. Experiments were performed at room temperature (21 8C-24 8C). For synchronization of recording and imaging, an output signal from the camera was also used to trigger electrophysiological recording.
| MEAs
For MEA experiments, 1-well MEA plates (60MEA200/30iR-Ti; Multi-Channel Systems, T€ ubingen, Germany) were used. MEA plates were sterilized by autoclaving and treated with FBS before coating with 0.1% polyethyleneimine and 10 mg/ml laminin. Neurons were plated on top of the electrodes in a drop containing 4 3 10 4 cells in 10 ml of Neurobasal Medium with FBS (see above). Once the cells adhered to the surface, the wells were slowly flooded with media and plates were returned to the incubator. The following day (DIV2), the medium was replaced with culture medium without serum containing adenoassociated virus. The medium was replaced every 3 to 4 days thereafter. All-trans retinal (R2500; Sigma-Aldrich, St. Louis, MO) was added to the culture medium to 1 mM final concentration before electrophysiological recordings. Consistently spiking neurons were used for recordings on DIV 10 to 19. A micropipette was used to add CTZ in a drop at 1:50 dilution of the MEA volume for a final concentration of 100 mM.
Recordings were carried out with an MEA 2100 Lite head stage and amplifier with a sample rate of 10,000 Hz. All MEA analysis was done offline with MC Rack software (MultiChannel Systems; RRID:SCR_ 014955) and NeuroExplorer (RRID:SCR_001818). Spikes were counted when the extracellular recorded signal exceeded 5 standard deviations of the baseline noise.
| Animals
Experimental procedures on cultured mouse neurons were approved by the Institutional Animal Care and Use Committee of Biopolis (Singapore). All experiments involving rats were carried out following the guidelines and protocols approved by the Institutional Animal Care and Use Committee of Central Michigan University.
Three male Sprague-Dawley rats (RRID:RGD_5508397) from an in-house colony were lesioned with 6-OHDA at 8 to 9 weeks of age (300-350 g body weight). Several months later, rats underwent surgery for virus injection and cannula placement and were tested for rotational behavior 1 month later. Rats were housed individually, with free access to food and water.
2.9 | Stereotactic surgery 2.9.1 | 6-OHDA lesioning Rats were under isoflurane anesthesia. The scalp was incised and retracted, and the skull cleaned and dried. Using a stereotaxic frame (Kopf Instruments, Tujunga, CA), rats received 6-OHDA injections into the right medial forebrain bundle (MFB) to produce unilateral lesions of the nigrostriatal pathway. A burr hole was drilled at the MFB coordinates established by Paxinos and Watson: AP 24.4, lateral 1.2, DV 27.8, measured from bregma. 6-OHDA hydrobromide (Sigma-Aldrich) was dissolved in 0.9% saline, containing 0.1% ascorbic acid, at a concentration of 3 mg/ml. Using a 10-ml Hamilton syringe, 6-OHDA was injected at a rate of 0.33 ml/min for a total of 4 ml, or 12 mg of 6-OHDA.
The needle was kept in place for 2 min following injection, and removed over an additional period of 2 min.
| Virus injection
Burr holes were drilled on the right side at coordinates (from Bregma) AP 1 1, lateral 1 2.7, and AAV-LMO4 was injected into the right striatum by lowering a 35G beveled injection needle attached to a 10-ml NanoFil syringe (World Precision Instruments, Sarasota, FL) to 25 DV. PARK ET AL.
| 3
A first injection of 0.8 ml was made over 8 min, using an automatic microinjector (Stoelting, 780310S); the needle was left in place for an additional 4 min. This was repeated twice, at 24.5 DV and at 24 DV.
| Cannula placement
Virus injection was followed by cannula placement. Burr holes were drilled on the left side at coordinates (from Bregma) AP 20.9, lateral 21.4. A 22G guide cannula (3.5-mm length; model C313GS, Plastics One, Roanoke, VA) was gently inserted through the left burr hole to penetrate the brain to the depth of the lateral ventricle. The guide cannula was held in place with dental acrylic bonded to a stainless steel screw anchored to the skull. A dummy cannula (C313DCS, 3.6-mm length) was inserted into each guide cannula and remained in place except during injections.
| Lateral ventricle injections
Water-soluble native CTZ was prepared at a concentration of 1.6 mM.
Rats received an intraventricular injection of 50 ml of CTZ solution or vehicle solution (buffer only without CTZ) before amphetamine injection and testing for rotational behavior. Assuming around 350 ml of cerebrospinal fluid (CSF), the final concentration of CTZ in the CSF is expected to be around 200 mM. The injections were performed at a rate of 0.5 ll/min using an automatic injector, a Hamilton syringe, and an internal cannula injector (Plastics One) that extended 1 mm beyond the tip of the guide cannula.
| Rotational behavior
Amphetamine rotation was used to assess the percentage of dopaminergic fiber loss within the striatum after 6-OHDA surgery, and the level of recovery following viral injection and CTZ or vehicle application. For each test, the animal was given an intraperitoneal injection of 2.5 mg/kg of amphetamine and immediately placed into a 25-cm-diameter flat-bottom bucket. Movements were recorded with a video camera for 60 min.
The number of rotations within 5-min bins was counted. 
| Histological analysis of rat brains
| Statistical analysis
Data are presented as mean 6 SEM. All statistical tests were performed in SPSS (IBM). Comparisons between two groups were performed with the unpaired Student t test (2 tailed). A p value < .05 was considered statistically significant. (Kim et al., 2011) , "slow burn" (SB) (Welsh et al., 2009) , and GLucM23 (M23) (Lindberg et al., 2013) . Amino acid changes are highlighted. (b) Comparison of bioluminescence emission of GLuc variants. HEK293 cells were lipofected with pcDNA3.1 plasmids of the different GLuc variants fused to VChR1-EYFP. Fluorescence of the EYFP reporter was used to normalize luminance from the GLuc variants. CTZ was added to a final concentration as indicated. Luminance was measured in an IVIS system. The intensity of light emission is represented by pseudo-colors, with red areas representing the highest amount of light emission, and blue/ violet areas representing the least. (c) Comparison of radiance of GLuc variants at 50 mM concentration of CTZ. IVIS measurements of 4 individual samples for each variant were graphed. GLucM23 emits significantly more photons than either wild-type GLuc (p 5 .002235) or superluminescent GLuc (p 5 .007356).
| R E S U LTS
3.1 | GLucM23 emits more light than wild-type GLuc GLucM23 was generated through random mutagenesis by error-prone PCR (Lindberg et al., 2013) and contains five amino acid changes compared with wild-type GLuc: K25E, M35L, V88D, M102I, and G159D ( Figure 1a ). We fused GLucM23 to VChR1 (Ernst et al., 2008; Zhang et al., 2008) to generate LMO4 (GLucM23-VChR1-EYFP) and to the anion channelrhodopsin iChloC (Wietek et al., 2015) to create the inhibitory iLMO4 (GLucM23-iChloC-EYFP).
GLucM23 reportedly has roughly 10-fold higher luminescence output than the wild-type luciferase (Lindberg et al., 2013) . Because this comparison was carried out with the luciferase either bound to the outer cell membrane or localized to the endoplasmic reticulum, we first examined the light emission of GLucM23 under conditions appropriate for use in LMOs. We therefore measured light emission from GLucM23 when fused to VChR1, to permit direct comparison with previous LMO versions with luciferase-VChR1 fusions. The different GLuc variants were fused to VChR1 using the same 15-amino acid linker (Berglund et al., 2013) ; levels of expression of the different constructs were comparable, as determined by measuring fluorescent emission from the attached EYFP reporter. When treated with the luciferase substrate, CTZ, the GLucM23 moiety in LMO4 was significantly brighter than either wild-type or superluminescent GLuc and was comparable in bioluminescence activity to the sbGLuc moiety in LMO3 (Figure 1b,c) .
| Higher coupling efficiency of GLucM23 improves functional properties of LMO4 and iLMO4
To evaluate the performance of LMO4 and iLMO4, whole-cell patch clamp recordings were made from cultured hippocampal neurons expressing these constructs. We began by measuring, under voltage clamp conditions, the photocurrents evoked by exciting the opsin actuators directly via illumination by an arc lamp (470 nm). For cells expressing LMO4, illumination evoked an inward photocurrent due to activation of VChR1 (Figure 2a ). This current reached a peak within a few milliseconds and exhibited a sustained plateau that persisted for as long as the excitation light was maintained (1 s in the example shown in Figure 2a ). The photocurrents evoked by such direct activation of LMO4 were quite large; when measured at a holding potential of 260 mV, peak photocurrent amplitude ranged In contrast, illumination of neurons expressing iLMO4 generated outward photocurrents (Figure 2c ). These currents also reached a peak rapidly but decreased with sustained activation (4 s for the example shown in Figure 2c ). The reversal potential for this current was approximately 260 mV, consistent with the Cl 2 equilibrium potential of 264 mV in our experimental conditions. Photocurrents evoked in neurons expressing iLMO4 were smaller than those evoked in neurons expressing LMO4 (Figure 2d) ; at a holding potential of 240 mV, mean peak amplitude of these photocurrents was 97 6 13 pA (n 5 13).
To determine the effectiveness of these new LMOs for chemogenetic control of neuronal activity, we measured the ability of CTZ to induce currents in cultured hippocampal neurons expressing LMO4 or iLMO4. In these experiments, bioluminescence emission from the GLucM23 moiety was monitored simultaneously to define the timing of LMO activation during CTZ treatment (Berglund et al., 2013 (Berglund et al., , 2016 .
Local application of CTZ onto LMO4-expressing neurons yielded bioluminescence emission and simultaneous activation of an inward current ( Figure 3a ). This inward current generally tracked the time course of the CTZ-induced light signal and has a mean peak amplitude of 336 6 77 pA (n 5 18). Similarly, treatment of iLMO4-expressing neurons with CTZ induced an outward current (Figure 3b ). This current also tracked the timing of the CTZ-induced bioluminescence signal and had a mean amplitude (at 240 mV) of 39 6 6 pA (n 5 13).
One of the most important determinants of LMO function is the efficiency of coupling between the luciferase light source and the opsin actuator, with 10-fold improvement in coupling efficiency from LMO1 to LMO2, and again from LMO2 to LMO3, leading to the first probe that allows noninvasive manipulation of animal behavior (Berglund et al., 2013 (Berglund et al., , 2016 . To determine the coupling efficiencies of LMO4 and iLMO4, we employed the procedure introduced by Berglund et al. (2013) . In brief, this procedure compares the magnitude of currents induced by CTZ with those evoked by maximal exposure to light from In general, there was a good correlation between the magnitude of CTZ-induced currents and lamp-induced currents for both LMO4 (Figure 4a ) and iLMO4 (Figure 4b ). For each LMO, there was a roughly linear relationship between the two responses (r 2 5 0.93 for LMO4 and 0.95 for iLMO4). Linear regression analysis of the slopes of these functions yielded estimates of the coupling efficiency. For LMO4, the coupling efficiency was 26% 6 7%. This value is remarkably high, approximately 2.6-fold higher than LMO3, the most efficient LMO previously described (Berglund et al., 2016) . The coupling efficiency for iLMO4 was even higher, being 36% 6 6%. As can be seen by comparing the properties of these LMO4 versions with previous generations of LMOs (Table I) , LMO4 and iLMO4 each represent substantial improvements in performance compared with previous LMOs.
| Chemogenetic and optogenetic control of neuronal activity by LMO4 and iLMO4
To examine the ability of LMO4 and iLMO4 to control neuronal activity, we examined their effects on the membrane potential of cultured hippocampal neurons expressing these LMOs. Exposure to arc lamp light depolarized the membrane potential and evoked action potentials in neurons expressing LMO4. Conversely, such illumination hyperpolarized iLMO4-expressing neurons and inhibited their ability to fire action potentials in response to depolarizing current steps. Thus, the VChR1 and iChloC opsin moieties retain their ability to control membrane potential, as expected from their ability to generate photocurrents ( Figure 2) .
To determine the ability of the new LMOs to control neuronal activity via chemogenetics, we next examined the effects of CTZ treatment. For the case of neurons expressing LMO4, CTZ treatment produced a transient depolarization of the membrane potential (Figure 5a ).
The mean amplitude of these CTZ-induced membrane potential changes was 12.6 6 6.6 mV (n 5 8). For these cultured hippocampal CTZ-induced increase in EPSP frequency (Figure 5f ). Under these conditions, CTZ treatment inhibited the ability of the iLMO4expressing neurons to fire action potentials in response to brief depolarizing current pulses (Figure 5g ). This suggests that the increase in EPSP frequency observed in the absence of kynurenic acid was due to disinhibition of presynaptic excitatory neurons that received inhibitory synaptic input from interneurons. The same results were observed in response to arc lamp illumination (Figure 5b,c) . Thus, iLMO4 expression is sufficient to produce CTZ-induced suppression of action potential firing in cultured hippocampal neurons.
We also used multielectrode extracellular recordings to examine the ability of iLMO4 to silence neuronal populations ( Figures 6   and 7 ). For these experiments, we transduced the entire population of rat embryonic cortical neurons in an MEA well with AAV-hSyn-iLMO4, using a virus titer that yielded transduction of most neurons by iLMO4 (Figure 6a ). The effects of CTZ were compared with that of an arc lamp. Photostimulation of iLMO4 resulted in complete silencing of spontaneous spiking activity that started and ended precisely with the application of light (see Figure 6b for individual recording example, and Figure 7b for mean spiking activity across several electrodes; t20, 14.210, p 5 3.2495E-12, n 5 21).
In contrast, spiking frequency was increased in spontaneously spiking neuronal cultures expressing the activating LMO4 (Figure 7a Spiking frequency increased significantly when neurons were exposed to light from an arc lamp (p < .0001). (b-d) Neurons were transduced with AAV-hSyn-iLMO4. Spiking frequency decreased significantly when neurons were exposed to light from an arc lamp (b; p < .0001) and with application of 50 mM CTZ (d; p < .001), but did not change significantly with application of 0.5 mM CTZ (c).
| LMO4 attenuates rotational behavior in 6-OHDA-lesioned rats in vivo
We used an established paradigm for testing the efficacy of LMO4 to affect behavior. Unilateral destruction of dopaminergic fibers to the striatum by chemical lesioning of the MFB induces ipsiversive circling behavior in rats after amphetamine stimulation (Hefti, Melamed, Sahakian, & Wurtman, 1980) . Ipsiversive rotations can be reduced by reconstituting dopaminergic drive directly from the striatum-for example, by transplantation of dopaminergic neurons (Dunnett, Bj€ orklund, Stenevi, & Iversen, 1981) . We assessed whether viral-mediated LMO4 expression in the right striatum would attenuate amphetamine-induced right rotations with CTZ application to the ventricular system. We used only male animals for these studies, as our focus was on comparing the change in rotations within individual animals after application of CTZ Figure 8a ). In contrast, ipsiversive rotations in CTZ-injected animals were significantly decreased in the initial 15 min after CTZ application; rotations returned to the expected number of turns typical for a given animal by the last 15 min (Figure 8a ; t2 5 12.509, p 5 .003165, n 5 3 per group). Robust expression of LMO4 in the striatum was confirmed by EYFP expression in serial sections (Figure 8b ).
| DISCUSSION
This study reveals that GLucM23, a recently described variant of GLuc, is an efficient light source for activating optogenetic elements in bioluminescence-driven optogenetics. The fusion of GLucM23 with
Volvox channelrhodopsin-1 and the anion channelrhodopsin iChloC, a depolarizing and hyperpolarizing channelrhodopsin, respectively, produced LMO4 and iLMO4. Both LMOs proved very efficient in activating and silencing neurons, respectively, via CTZ-mediated light emission of GLucM23. Bioluminescence-driven optogenetic activation and silencing was demonstrated in single-cell recordings, in multielectrode recordings, and by affecting behavior.
Higher coupling efficiencies between the light-emitting luciferase and the light-sensing opsin can be achieved, in principle, by increasing either or both the light emission of the luciferase and the light sensitivity of the opsin. We previously improved performance of LMOs by switching out ChR2 in LMO1 with VChR1 in LMO2, then improved from subthreshold depolarization to eliciting action potentials by switching from wild-type GLuc in LMO2 (Berglund et al., 2013) to slow burn GLuc in LMO3 (Berglund et al., 2016) . The improvement in each round was about 10-fold (see also Table I ). The coupling efficiency of FIG URE 8 Amphetamine-induced rotational behavior attenuated by LMO4. Adult male rats (n 5 3) were injected with 6-OHDA into the right hemisphere with coordinates set to target the medial forebrain bundle. AAV-hSyn-LMO4 was injected into the right striatum. A lateral ventricle cannula was implanted into the left hemisphere. For testing rotational behavior, rats were injected intraperitoneally with amphetamine (2.5 mg/kg), and ipsilateral rotations were counted for the first and last 15 min of an hour. (a) The same three animals were tested with vehicle injection (Amph 1 veh) and with CTZ injection at the time of amphetamine application (Amph 1 CTZ; final concentration of 200 mM in CSF). Bars indicate mean percentage of amphetamine-induced ipsilateral rotations during the first 15 min of testing. Data are normalized relative to number of turns during the last 15 min (between 45 and 60 min after amphetamine injection). CTZ, but not vehicle, decreases the number of ipsilateral rotations significantly for the first 15 min after injection (p 5 .002017). (b) Fluorescence images of a coronal section from a rat at the end of the experiment. Stippled lines in overview image (53) mark the right and left striatum; higher magnification image (203) zooms in on right striatum. Neurons expressing LMO4 show green fluorescence from the EYFP reporter.
